The Conversation (0)
Hempsana has launched its Campaign on the Investing News network
Hempsana focuses on providing well-engineered products and services that fuel its robust premier product development IP portfolio, as well as a focus on rare cannabinoids such as CBN, CBG and Delta-8 THC.
Hempsana’s broad portfolio also includes “As-A-Service” offerings, wholesale distribution and white labeling. The company’s team of experts continuously explores and develops solutions and formulations for businesses to resell premium products that are customized and packaged for medical sales or for the recreational market.
Hempsana’s Company Highlights
- Hempsana is a licensed cannabis extraction and purification company producing high-quality cannabinoid oils and cannabis-infused products.
- The company has diverse revenue streams consisting primarily of retail, wholesale and manufacturing channels.
- Hempsana offers high-quality cannabinoid products, including crude oil, distillates and isolates in increasingly high purities. Its services involve several avenues of revenue, including wholesale, Extraction-As-A-Service and white label service channels.
- The company leverages the limited rare cannabinoid space in Canada in hopes of carving a spot as a pioneer in high-quality extraction and processing of cannabinoids like CBN, CBG and Delta-8 THC.
- Hempsana looks forward to developing and delivering rare cannabinoid products to market, including innovative cannabinoid formulations for cosmeceuticals, nutraceuticals and pharmaceutical use.
- Hempsana holds a signed Letter of Intent with Canbud Distribution (CSE:CBDX, FSE:CD0) for the development and manufacturing of CBD products for distribution to Canbud’s medical-patient channel.
HMPS:CC